Weight loss with pharmacotherapy

DRUG3 trials

Sponsors

University of Minnesota, University of Kansas Medical Center, TecSalud Investigación Clínica

Conditions

Early Stage Endometrial CancerEndometrial Cancer SurvivorsObesity & OverweightSevere ObesityWeight Management

Phase 2

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

CompletedNCT02496611

University of MinnesotaSevere Obesity

Start: 2015-12-31End: 2020-08-14Updated: 2022-01-03

Unknown Phase

Weight Loss Management in Endometrial Cancer Survivors

Active, not recruitingNCT06877572

University of Kansas Medical CenterEarly Stage Endometrial Cancer, Endometrial Cancer Survivors, Weight Management

Start: 2025-03-25End: 2030-10-01Target: 50Updated: 2026-08-12

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

CompletedNCT07455630

TecSalud Investigación ClínicaObesity & Overweight

Start: 2023-06-20End: 2024-09-30Updated: 2026-03-06

Related Papers

Meal Replacement Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity.

2026-06-11